23andMe
using human genetics to create meaningful therapeutics for diseases with high unmet need in oncology and immunology | 23andMe
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
4 of 39
Related slides by other companies
GreenLight
SPAC
August 2021
human health applications vaccines therapies antibodies solutions for pandemics and more equitable access to novel therapies for grave diseases | GreenLight
Adobe
Investor Day
October 2022
changing the world through digital experiences a | Adobe
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io